The University of Chicago Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Elliot Gershon and Sarah Keedy.
Elliot Gershon
Connection Strength
3.979
Sarah Keedy
  1. Genetic analysis of psychosis Biotypes: shared Ancestry-adjusted polygenic risk and unique genomic associations. Mol Psychiatry. 2025 Jun; 30(6):2673-2685.
    View in: PubMed
    Score: 0.229
  2. Genetic Analysis of Psychosis Biotypes: Shared Ancestry-Adjusted Polygenic Risk and Unique Genomic Associations. medRxiv. 2024 Dec 08.
    View in: PubMed
    Score: 0.229
  3. Real-time facial emotion recognition deficits across the psychosis spectrum: A B-SNIP Study. Schizophr Res. 2022 05; 243:489-499.
    View in: PubMed
    Score: 0.186
  4. An opportunity for primary prevention research in psychotic disorders. Schizophr Res. 2022 05; 243:433-439.
    View in: PubMed
    Score: 0.181
  5. Resting state auditory-language cortex connectivity is associated with hallucinations in clinical and biological subtypes of psychotic disorders. Neuroimage Clin. 2020; 27:102358.
    View in: PubMed
    Score: 0.169
  6. Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder. Schizophr Res. 2020 09; 223:148-157.
    View in: PubMed
    Score: 0.168
  7. No connectivity alterations for striatum, default mode, or salience network in association with self-reported antipsychotic medication dose in a large chronic patient group. Schizophr Res. 2020 09; 223:359-360.
    View in: PubMed
    Score: 0.168
  8. GWAS significance thresholds for deep phenotyping studies can depend upon minor allele frequencies and sample size. Mol Psychiatry. 2021 06; 26(6):2048-2055.
    View in: PubMed
    Score: 0.164
  9. NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosis. Transl Psychiatry. 2019 09 17; 9(1):230.
    View in: PubMed
    Score: 0.159
  10. Genetic analysis of deep phenotyping projects in common disorders. Schizophr Res. 2018 05; 195:51-57.
    View in: PubMed
    Score: 0.139
  11. Brain Age Disparities in Psychosis Across DSM Diagnoses and B-SNIP Biotypes. Schizophr Bull. 2026 Jan 16; 52(1).
    View in: PubMed
    Score: 0.062
  12. Evaluating the Exposome Score for Schizophrenia in a Transdiagnostic Psychosis Cohort: Associations With Psychosis Risk, Symptom Severity, and Personality Traits. Schizophr Bull. 2025 Sep 08; 51(5):1454-1463.
    View in: PubMed
    Score: 0.060
  13. The BAsic NeuroCognitive Continuum (BANCC): Delineation of dimensional and categorical features for etiological and treatment investigations of idiopathic psychosis. Psychiatry Clin Neurosci. 2025 Nov; 79(11):747-756.
    View in: PubMed
    Score: 0.060
  14. Differentiating biomarker features and familial characteristics of B-SNIP psychosis Biotypes. Transl Psychiatry. 2025 Aug 14; 15(1):281.
    View in: PubMed
    Score: 0.060
  15. Exposotypes in psychotic disorders. Sci Rep. 2025 Aug 08; 15(1):29003.
    View in: PubMed
    Score: 0.060
  16. Neural fingerprints of data driven cognitive subtypes across the psychosis spectrum: a B-SNIP study. Transl Psychiatry. 2025 Jul 02; 15(1):224.
    View in: PubMed
    Score: 0.059
  17. Impact of Polygenic Interactions With Anticholinergic Burden on Cognition and Brain Structure in Psychosis Spectrum Disorders. Am J Psychiatry. 2025 Aug 01; 182(8):751-762.
    View in: PubMed
    Score: 0.059
  18. Cerebral perfusion differences in the visual cortex and fusiform subregions across the psychosis spectrum. Front Psychiatry. 2025; 16:1566184.
    View in: PubMed
    Score: 0.059
  19. White Matter, Cognition, and Electrophysiological Variables in Bipolar Disorder: Using Multimodal Integration of Biomarker Variables Associated With Bipolar Disorder to Elucidate Deficits. Bipolar Disord. 2025 May; 27(3):205-216.
    View in: PubMed
    Score: 0.058
  20. Neuroanatomical Deficits in Visual Cortex Subregions of Individuals with Psychosis Spectrum Disorders linked to Symptoms, Cognition, and Childhood Trauma. medRxiv. 2025 Feb 13.
    View in: PubMed
    Score: 0.058
  21. Characterizing the relationship between personality dimensions and psychosis-specific clinical characteristics. Schizophr Res. 2025 Feb; 276:88-96.
    View in: PubMed
    Score: 0.058
  22. Cognitive performance and differentiation of B-SNIP psychosis Biotypes: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT) - 2. Biomark Neuropsychiatry. 2025 Jun; 12.
    View in: PubMed
    Score: 0.057
  23. Characterizing the Relationship between Personality Dimensions and Psychosis-Specific Clinical Characteristics. medRxiv. 2024 Jun 07.
    View in: PubMed
    Score: 0.055
  24. Differentiating Biomarker Features and Familial Characteristics of B-SNIP Psychosis Biotypes. Res Sq. 2024 Jan 05.
    View in: PubMed
    Score: 0.054
  25. Categorical and Dimensional Approaches for Psychiatric Classification and Treatment Targeting: Considerations from Psychosis Biotypes. Adv Neurobiol. 2024; 40:685-723.
    View in: PubMed
    Score: 0.054
  26. Clinical characterization and differentiation of B-SNIP psychosis Biotypes: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT)-1. Schizophr Res. 2023 10; 260:143-151.
    View in: PubMed
    Score: 0.052
  27. Peripheral inflammatory subgroup differences in anterior Default Mode network and multiplex functional network topology are associated with cognition in psychosis. Brain Behav Immun. 2023 11; 114:3-15.
    View in: PubMed
    Score: 0.052
  28. Characterization of childhood trauma, hippocampal mediation and Cannabis use in a large dataset of psychosis and non-psychosis individuals. Schizophr Res. 2023 05; 255:102-109.
    View in: PubMed
    Score: 0.051
  29. Peripheral inflammation is associated with impairments of inhibitory behavioral control and visual sensorimotor function in psychotic disorders. Schizophr Res. 2023 05; 255:69-78.
    View in: PubMed
    Score: 0.051
  30. Monoallelic and biallelic mutations in RELN underlie a graded series of neurodevelopmental disorders. Brain. 2022 09 14; 145(9):3274-3287.
    View in: PubMed
    Score: 0.049
  31. Inflammation subtypes in psychosis and their relationships with genetic risk for psychiatric and cardiometabolic disorders. Brain Behav Immun Health. 2022 Jul; 22:100459.
    View in: PubMed
    Score: 0.047
  32. A subtype of institutionalized patients with schizophrenia characterized by pronounced subcortical and cognitive deficits. Neuropsychopharmacology. 2022 11; 47(12):2024-2032.
    View in: PubMed
    Score: 0.047
  33. Using psychosis biotypes and the Framingham model for parsing psychosis biology. Schizophr Res. 2022 04; 242:132-134.
    View in: PubMed
    Score: 0.047
  34. Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium. Schizophr Bull. 2022 01 21; 48(1):56-68.
    View in: PubMed
    Score: 0.047
  35. Subtyping Schizophrenia Patients Based on Patterns of Structural Brain Alterations. Schizophr Bull. 2022 01 21; 48(1):241-250.
    View in: PubMed
    Score: 0.047
  36. Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2022 03 08; 113:110464.
    View in: PubMed
    Score: 0.046
  37. Neural Processing of Repeated Emotional Scenes in Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder. Schizophr Bull. 2021 08 21; 47(5):1473-1481.
    View in: PubMed
    Score: 0.045
  38. Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features. Am J Psychiatry. 2021 10 01; 178(10):952-964.
    View in: PubMed
    Score: 0.045
  39. Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders. Neuropsychopharmacology. 2021 09; 46(10):1802-1810.
    View in: PubMed
    Score: 0.045
  40. Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis. Mol Psychiatry. 2021 07; 26(7):3430-3443.
    View in: PubMed
    Score: 0.043
  41. Biotyping in psychosis: using multiple computational approaches with one data set. Neuropsychopharmacology. 2021 01; 46(1):143-155.
    View in: PubMed
    Score: 0.043
  42. Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis. Schizophr Bull. 2020 Sep 21; 46(5):1269-1281.
    View in: PubMed
    Score: 0.043
  43. Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relatives. Schizophr Res. 2020 09; 223:236-241.
    View in: PubMed
    Score: 0.042
  44. Auditory paired-stimuli responses across the psychosis and bipolar spectrum and their relationship to clinical features. Biomark Neuropsychiatry. 2020 Dec; 3.
    View in: PubMed
    Score: 0.042
  45. Testing Psychosis Phenotypes From Bipolar-Schizophrenia Network for Intermediate Phenotypes for Clinical Application: Biotype Characteristics and Targets. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 08; 5(8):808-818.
    View in: PubMed
    Score: 0.042
  46. NMDA receptor antibody seropositivity in psychosis: A pilot study from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP). Schizophr Res. 2020 04; 218:318-320.
    View in: PubMed
    Score: 0.041
  47. Brain gray matter network organization in psychotic disorders. Neuropsychopharmacology. 2020 03; 45(4):666-674.
    View in: PubMed
    Score: 0.040
  48. Intrinsic neural activity differences in psychosis biotypes: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium. Biomark Neuropsychiatry. 2019 Dec; 1.
    View in: PubMed
    Score: 0.040
  49. Electrophysiological correlates of emotional scene processing in bipolar disorder. J Psychiatr Res. 2020 01; 120:83-90.
    View in: PubMed
    Score: 0.040
  50. Auditory steady-state EEG response across the schizo-bipolar spectrum. Schizophr Res. 2019 07; 209:218-226.
    View in: PubMed
    Score: 0.039
  51. Alterations in intrinsic fronto-thalamo-parietal connectivity are associated with cognitive control deficits in psychotic disorders. Hum Brain Mapp. 2019 01; 40(1):163-174.
    View in: PubMed
    Score: 0.037
  52. Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia. Schizophr Res. 2018 12; 202:173-179.
    View in: PubMed
    Score: 0.037
  53. Cognitive burden of anticholinergic medications in psychotic disorders. Schizophr Res. 2017 12; 190:129-135.
    View in: PubMed
    Score: 0.034
  54. Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Mar 01; 1(2):141-151.
    View in: PubMed
    Score: 0.030
  55. Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. Schizophr Bull. 2014 Nov; 40(6):1374-84.
    View in: PubMed
    Score: 0.027
  56. Neurophysiological evidence of corollary discharge function during vocalization in psychotic patients and their nonpsychotic first-degree relatives. Schizophr Bull. 2013 Nov; 39(6):1272-80.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.